DiaMedica Receives FDA Feedback on DM199 Preeclampsia Nonclinical Program
Go back to DiaMedica Receives FDA Feedback on DM199 Preeclampsia Nonclinical Program| (NASDAQ: DMAC) | Delayed: 8.31 -0.11 (1.31%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $8.42 | 52 Week High | $ | |||
| Open | $8.50 | 52 Week Low | $ | |||
| Day High | $8.61 | P/E | N/A | |||
| Day Low | $8.16 | EPS | $ | |||
| Volume | 150,322 | |||||



